Human Faecal Carriage Of Antibiotic Resistance And Molecular Characterization Of ESBL Producing Escherichia Coli In The Community.

Introduction The human gut naturally contains the bacterium Escherichia coli. Colonisation of the gastrointestinal tract by Escherichia coli, which can cause ESBL infections, is a known risk factor. Carrying of ESBL-producing Escherichia coli is on the rise, and these infections are currently affecting the community. Because of their ability to cause infections and spread resistance to other bacteria, ESBL-producing strains pose a threat to public health. The purpose of this research was to quantify the prevalence of ESBLs produced by community-dwelling Escherichia coli bacteria. Methods: The urban practice area of Sri Siddhartha Medical College, Tumkur, was randomly selected from a pool of 860 healthy persons. After participants' stool samples were obtained, they were cultured on MacConkey agar plates and processed in accordance with established protocols for the isolation and identification of Escherichia coli. All of the samples were tested using established protocols to identify any instances of multidrug resistance to routinely used antibiotics. Multiplex-PCR was used to identify resistance genes and CLSI phenotypic testing were used to identify ESBL producers. Results: Out of 860 stool samples, 67.6% tested positive for Escherichia coli. The most common antibiotics that bacteria showed resistance to were fluoroquinolones (51%), cephalosporins (48%), and tetracycline (47%). A total of 54% of the colonisers in the community were determined to be multi-drug resistant. Multiplex PCR was performed to identify AMR genes CTX-M (82%), SHV (13%), and Oxa-10/11 (4%), and 432 (50.2%) of the isolates were determined to be ESBL producers using CLSI procedures.